According to a recent study, blocking HO-1 in FLT-ITD+ AML cells synergizes with quizartinib in inducing apoptosis in TKI-resistant/-sensitive FLT3-ITD+ cells. This evidence concerns the gene FLT3 and acute myeloid leukemia.